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aBstraCt
In this article, Fuchs’ endothelial dystrophy is discussed. The symptoms and early treatment are analysed, as well as 
the hereditary nature of the disease. Surgical approach is thoroughly analysed and the advantages and disadvantages 
of a potential combined procedure (partial keratoplasty and cataract surgery) are discussed.
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introduCtion
Fuchs’ endothelial dystrophy is a non-inflamma-
tory dystrophy involving the endothelial layer of the 
cornea [1]. The endothelium, which is a monolayer 
of cells that keeps the cornea clear by pumping out 
excess fluid that could cause corneal swelling. 
In the initial stages of Fuchs’ endothelial dystro-
phy, a progressive accumulation of focal excrescences 
(known as guttae) is observed, as well as thickening 
of Descemet’s membrane. The normal attrition rate 
for endothelial cells is 0.6% per year [2]. In patients 
with Fuchs’ endothelial dystrophy this rate is much 
higher. As a result, the remaining cells can no longer 
pump out the excess fluid and oedema occurs [3]. 
What should be noted is that Fuchs’ endothelial 
dystrophy is defined as the accumulation of corneal 
guttae with stromal oedema [3]. The pathogenesis 
of the disease is unclear. Some possible factors may 
be sex hormones, inflammation, and endothelial cell 
apoptosis [4].
The disease usually affects both eyes and causes 
a gradual decline in vision due to corneal oedema 
and clouding. As the disorder progresses, swelling 
of the cornea can cause blisters on the front of the 
cornea known as epithelial bullae. This condition is 
known as bullous keratopathy. The damage to the 
cornea in Fuchs’ endothelial dystrophy can be so 
severe as to cause corneal blindness [1]. Some com-
mon symptoms are: glare and sensitivity to light, eye 
pain, blurred vision, poor vision upon awakening 
that may improve later in the day, and foreign body 
sensation. The diagnosis of the disease is made via 
biomicroscopy and other modalities ophthalmol-
ogists have, such as corneal pachymetry, confocal 
microscopy, and specular microscopy.
The progression of the disease can be divided 
into four stages [5]. In stage one, the patient experi-
ences no symptoms and there are a few to moderate 
corneal guttae. The vision in this stage is unaffected. 
In stage two there is mild to moderate loss of vision 
but there is still no pain. In the clinical examination, 
moderate to numerous corneal guttae are observed 
and there is mild corneal oedema. The vision is 
mildly reduced. In the third stage, there is moderate 
to severe loss of vision and pain. Clinically, conflu-
ent corneal guttae are observed, as well as moderate 
to severe corneal oedema and epithelial bullae. In 
the final stage (four), there is severe loss of vision 
but the pain is reduced. Fewer epithelial bullae are 
observed as well as subepithelial scarring.
Fuchs’ dystrophy is often inherited in an au-
tosomal dominant manner [6]. This means that 
there is a 50% chance for a person to develop the 
disease if one of the parents has it. Consequently, 
there is no way of preventing the disease and its 
progress. The treatment of the disease begins when 
the patient starts noticing fluctuation in vision. The 
early treatment usually involves hypertonic saline 
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drops and/or ointments. The hypertonic saline helps 
to evaporate fluid off the cornea, leading to a mini-
misation of oedema. 
As the disease progresses there may be a need for 
surgical treatment. The most popular surgical proce-
dure is currently Descemet’s membrane endothelial 
keratoplasty (DMEK) or Descemet’s stripping auto-
mated endothelial keratoplasty (DSAEK).
surgiCaL treatMent
When performing cataract surgery on a patient 
with Fuchs’ dystrophy, one should be extremely cau-
tious. The patient should be thoroughly informed 
about the possibility of corneal decompensation 
after surgery. When the Fuchs’ dystrophy is mild, 
there is no need for endothelial keratoplasty [7]. 
The cataract extraction should be performed when 
the nucleus is still soft, so there is no need for 
high-energy ultrasound. The endothelium should 
be protected with the use of viscoelastic. 
In severe Fuchs’ dystrophy there is an indication 
for combined cataract and DSAEK surgery7. When 
performing DSAEK, there is change in the intraoc-
ular lens (IOL) calculation. There are studies [8] 
that report a slightly hyperopic swift in eyes under-
going such surgeries. In patients with severe Fuchs’ 
the IOL should not be hydrophilic because it can 
become opacified from the air used during DSAEK. 
In combined cases the use of viscoelastic is not indi-
cated because it reduces the possibility of the graft 
attaching to the cornea. Insert IOL, inflating the 
bag with BSS. If viscoelastic is used, then it has to 
be washed out thoroughly. Extra capsular cataract 
extraction remains a viable option but has more 
complications than phacoemulsification and creates 
more astigmatism.
It has been reported by many studies [9, 10] that 
the visual acuity of patients who undergo DMEK 
or DSAEK significantly improves. Partial corne-
al transplant procedures are preferred by surgeons, 
instead of full-thickness corneal transplants. The 
reasons are the following: a. because the eye surface 
is kept intact, thus remaining more resistant to in-
jury and infection, b. there is minimal change in 
refraction because only the endothelial layer (~5% 
of the cornea) is replaced, c. suture-related problems 
are significantly reduced, and d. visual recovery is 
significantly faster. 
reFerenCes
1. Krachmer J, Palay DA. External Disease and Cornea, Section 8. Basic 
and Clinical Science Course. In: Cornea Atlas. AAO, Philadelphia 
2006: Elsevier.
2. Bahn CF, Falls HF, Varley GA, et al. Classification of corneal endothelial 
disorders based on neural crest origin. Ophthalmology. 1984; 91(6): 
558–563, indexed in Pubmed: 6462621.
3. Suh LH, Vaughn Emerson M, Jun AS. Fuchs endothelial dystrophy: 
Pathogenesis and management. In: Reinhard T, Larkin F. ed. Cornea 
and External Disease, Corneal Allotransplantation, Allergic Disease 
and Trachoma. Springer, Berlin-Heidelberg 2010.
4. Borboli S, Colby K. Mechanisms of disease: Fuchs’ endothelial dys-
trophy. Ophthalmol Clin North Am. 2002; 15(1): 17–25, indexed in 
Pubmed: 12064077.
5. Adamis AP, Filatov V, Tripathi BJ, et al. Fuchs’ endothelial dystrophy 
of the cornea. Surv Ophthalmol. 1993; 38(2): 149–168, indexed in 
Pubmed: 8235998.
6. Eghrari AO, Gottsch JD. Fuchs’ corneal dystrophy. Expert Rev Oph-
thalmol. 2010; 5(2): 147–159, doi:  10.1586/eop.10.8, indexed in 
Pubmed: 20625449.
7. Combined or separate cataract, DSAEK procedures in Fuchs’ dystro-
phy?  http://ophthalmologytimes.modernmedicine.com/ophthalmol-
ogytimes/news/modernmedicine/modern-medicine-feature-articles/
combined-or-separate-catarac.
8. Guerra FP, Anshu A, Price MO, et al. Descemet’s membrane endo-
thelial keratoplasty: prospective study of 1-year visual outcomes, 
graft survival, and endothelial cell loss. Ophthalmology. 2011; 
118(12): 2368–2373, doi: 10.1016/j.ophtha.2011.06.002, indexed in 
Pubmed: 21872938.
9. Guerra FP, Anshu A, Price MO, et al. Endothelial keratoplasty: fellow 
eyes comparison of Descemet stripping automated endothelial kera-
toplasty and Descemet membrane endothelial keratoplasty. Cornea. 
2011; 30(12): 1382–1386, doi:  10.1097/ICO.0b013e31821ddd25, 
indexed in Pubmed: 21993468.
10. Naveiras M, Lisa C, Almanzar D, et al. Combined Descemet’s 
membrane endothelial keratoplasty, phacoemulsification and 
intraocular lens implantation in Fuchs ´dystrophy. J Emmetropia. 
2013(4): 65–71.
